Skip to main content
Top

Current Cardiology Reports

Issue 4/2012

Content (19 Articles)

Letter to the Editor: Interobserver Variability of Heart-to-Mediastinum Ratio in I-123 MIBG Sympathetic Imaging

  • Open Access
  • Letter to the Editor

Ben F. Bulten, Roel L. F. van der Palen, Hanneke W. M. van Laarhoven, Livia Kapusta, Annelies M. C. Mavinkurve-Groothuis, Lioe-Fee de Geus-Oei

Can Bridge to Recovery Help to Reveal the Secrets of the Failing Heart?

  • Invited Commentary

Michael Ibrahim, Cesare Terracciano, Magdi H. Yacoub

Late Stent Thrombosis: The Last Remaining Obstacle in Coronary Interventional Therapy

  • Ischemic Heart Disease (S Brener, Section Editor)

Piera Capranzano, George Dangas

Preservation of Myocardium During Coronary Artery Bypass Surgery

  • Ischemic Heart Disease (S Brener, Section Editor)

Takeshi Kinoshita, Tohru Asai

Periprocedural Myocardial Enzyme Elevation: Prognostic Implications for Current Practice

  • Ischemic Heart Disease (S Brener, Section Editor)

Sanjum S. Sethi, Avtar Singh, Michael E. Farkouh

Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists in Atherosclerosis Prevention

  • Ischemic Heart Disease (S Brener, Section Editor)

Maria M. Patarroyo Aponte, Gary S. Francis

Regression of Atherosclerosis

  • Ischemic Heart Disease (S Brener, Section Editor)

Benoit J. Arsenault, Ekaterini A. Kritikou, Jean-Claude Tardif

New Anticoagulants in Ischemic Heart Disease

  • Ischemic Heart Disease (S Brener, Section Editor)

Lawrence Rajan, David J. Moliterno

Platelet Function and Inhibition in Ischemic Heart Disease

  • Ischemic Heart Disease (S Brener, Section Editor)

Annunziata Nusca, Giuseppe Patti

Coronary Stent Choice in Patients with Acute Myocardial Infarction

  • Management of Acute Coronary Syndromes (R Mehran, Section Editor)

Giulio G. Stefanini, Stephan Windecker

Which Antiplatelet Agent for Whom? Which Patient Populations Benefit Most from Novel Antiplatelet Agents (Ticagrelor, Prasugrel)?

  • Management of Acute Coronary Syndromes (R Mehran, Section Editor)

Christoph Varenhorst, Stefan James

Which Antithrombin for Whom? Identifying the Patient Population that Benefits Most from Novel Antithrombin Agents

  • Management of Acute Coronary Syndromes (R Mehran, Section Editor)

David A. Burke, Haider J. Warraich, Duane S. Pinto

Radial Versus Femoral Access for Percutaneous Coronary Intervention: Implications for Vascular Complications and Bleeding

  • Management of Acute Coronary Syndromes (R Mehran, Section Editor)

Sandeep Nathan, Sunil V. Rao

Risk Stratification and Timing of Revascularization: Which Patients Benefit from Early Versus Later Revascularization?

  • Management of Acute Coronary Syndromes (R Mehran, Section Editor)

Ian J. Sarembock, Dean J. Kereiakes

Is There Attenuation of Benefit of Invasive Therapy in Patients with Chronic Kidney Disease? Results from Randomized Trials and Registry Data

  • Management of Acute Coronary Syndromes (R Mehran, Section Editor)

Jennifer Yu, Sze-Yuan Ooi, Ziad Sergie, Usman Baber

Multivessel Versus Culprit-Only Revascularization: One Time Versus Staged Procedures for the ACS Population

  • Management of Acute Coronary Syndromes (R Mehran, Section Editor)

Pablo Codner, Ran Kornowski

Next-generation MRI contrast agents: preparing the field (Link opens in a new window)

New MRI contrast agents are reshaping diagnostic imaging, promising lower gadolinium exposure amid evolving practice guidelines. How can you optimise contrast selection, dosing, and patient care in this rapidly advancing field?

This content is intended for healthcare professionals outside of the UK.

Independent Medical Education Grant:
  • Bayer HealthCare Pharmaceuticals Inc.
Learn more Link opens in a new window
Image Credits
Abstract graphic of layered, concentric circular shapes in bright green, pink, blue, and purple on a dark blue background. The rings and segments form a complex radial pattern without text/© Springer Health+ IME